Redcare Pharmacy Shares Stage Impressive Recovery

The Dutch e-pharmacy pioneer Redcare Pharmacy has demonstrated a remarkable turnaround, with its shares surging following months of downward pressure. Investors are now questioning whether this signals a temporary rally or the beginning of a sustained recovery for the company.

The third quarter revealed a dramatic resurgence in Redcare’s German prescription business, a development that appears to be the primary catalyst for the positive shift. Prescription revenue in Germany soared by an impressive 82.1%, reaching €126 million. This performance marks a significant reversal after two consecutive quarters of declining prescription figures.

CEO Olaf Heinrich highlighted the company’s robust third-quarter momentum, noting “particularly strong double-digit quarterly growth rates in the German prescription segment.” The quarterly gains themselves doubled compared... Read more...